Sputnik-AstraZeneca human trials to begin next week in Azerbaijan, Middle East
- Country:
- Russia
Human trials of a vaccine combining the shot developed by Britain's AstraZeneca and Oxford University and Russia's Sputnik V shot will begin next week in Azerbaijan and some Middle East countries, a Russian official said on Thursday.
The first results of the joint trials are expected in March, the head of Russia's RDIF sovereign wealth fund, Kirill Dmitriev, said.
The RDIF fund is also going to announce joint trials of the Russian vaccine with a large Chinese company, Dmitriev said.
ALSO READ
-
Inside Russia’s SMR School, Where Nuclear Experience Shapes Future Energy Decisions
-
African Venture Capital Gets a Boost as Oxford Programme Builds Investor Connections
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
Russia’s Reach Beyond Borders Leaves Exiled Critics Living in Fear, UN Expert Warns
-
Ukraine Faces Another Bitter Winter as UN Inquiry Warns of Deepening Civilian Harm
Google News